International Paper Misses Q2 Sales, Guides Q3 EBITDA Below Consensus Amid EMEA Weakness
IP sits 45% above its 52-week low of $29.26.
Summary
International Paper reported Q2 2026 sales of $6.0 billion, missing consensus, and guided Q3 EBITDA below expectations. The EMEA segment posted an operating loss, and the company flagged potential goodwill impairment risk in that unit.
Key Events · Earnings and Guidance · IP
-
Q2 Sales Miss, Loss from Continuing Ops
Net sales of $6.004 billion missed the $6.18 billion consensus. Loss from continuing operations was $12 million, or $0.02 per share.
-
Q3 EBITDA Guidance Below Consensus
Management expects sequentially higher adjusted EBITDA in Q3 but guided below consensus, citing soft EMEA demand, higher input costs, and the temporary Pine Hill mill suspension.
-
PS EMEA Operating Loss and Goodwill Risk
The PS EMEA segment posted an $80 million operating loss. The company disclosed that the fair value of the PS EMEA reporting unit approximates its carrying value, making it sensitive to further deterioration.
-
Strategic Separation Update
The planned spin-off of the EMEA packaging business remains on track for completion within 12-15 months from the January 2026 announcement, with IP retaining a ~20% stake.
Analysis · IP · Manufacturing
International Paper's Q2 sales of $6.0 billion fell short of the $6.18 billion consensus, and the company guided Q3 EBITDA below expectations, citing soft EMEA demand and a temporary mill suspension. The PS EMEA segment swung to an operating loss, and the company disclosed that the fair value of that reporting unit is only approximating its carrying value after a prior impairment — a red flag for potential future write-downs. Against this backdrop, the planned spin-off of the EMEA business adds execution risk. The results confirm the operational challenges flagged in the recent 8-K, but the 10-Q provides the full financial picture and management's outlook.
At the time of this filing, IP was trading at $42.33 on NYSE in the Manufacturing sector, with a market capitalization of approximately $22.4B. The 52-week trading range was $29.26 to $50.25. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.